Sex- or age-related differences were not detected in the activity of dihydropyrimidine dehydrogenase from rat liver

Pharmacological Research

Volumn 35, Issue 2, 1997, Pages 103-106

  Tateishi, Tomonori ^a   Watanabe, Minoru ^a   Nakura, Hironori ^a   Tanaka, Masami ^a   Kumai, Toshio ^a   Kobayashi, Shinichi ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

5 Fluorouracil; Ageing; Dihydropyrimidine dehydrogenase; Gender difference; Sprague Dawley rats

Indexed keywords

DIHYDROFLUOROURACIL; DIHYDROPYRIMIDINE DEHYDROGENASE; DRUG METABOLITE; DRUG METABOLIZING ENZYME; FLUOROURACIL; FLUOROURACIL DERIVATIVE; LIVER ENZYME;

AGE; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG METABOLISM; ENZYME ACTIVITY; FEMALE; LIVER METABOLISM; LIVER WEIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE;

EID: 0030949968     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1996.0109     Document Type: Article

References (12)

1. Pinedo HM, Peters GF. Fluorouracil: Biochemistry and Pharmacology. J Clin Oncol. 6:1988;1653-1664.
2. Naguib FNM, el Kouni MH, Cha S. Enzymes of Uracil catabolism in normal and neoplastic human tissues. Cancer Res. 45:1985;5405-5412.
3. Woodhouse K, Wynne HA. Age-related changes in hepatic function; Implications for drug therapy. Drugs & Aging. 2:1992;243-255.
4. Harris RZ, Benet LZ, Schwartz JB. Gender effects in pharmacokinetics and pharmacodynamics. Drugs. 50:1995;222-239.
5. Imaoka S, Fujita S, Funae Y. Age-dependent expression of cytochrome P-450s in rat liver. Biochim Biophys Acta. 1097:1991;187-192.
6. Milano G, Etienne MC, Cassuto-Viguier E, Thyss A, Santini J, Frenay M, Renée N, Schneider M, Demard F. Influence of sex and age on fluorouracil clearance. J Clin Oncol. 10:1992;1171-1175.
7. Lu Z, Zhang R, Diasio RB. Population characteristics of hepatic dihydropyrimidine dehydrogenase activity, a key metabolic enzyme in 5-flourouracil chemotherapy. Clin Pharmacol Ther. 58:1995;512-522.
8. Etienne MC, Lagrange JL, Dassonville O, Fleming R, Thyss A, Renée N, Schneider M, Demard F, Milano G. Population study of dihydropyrimidine dehydrogenase in cancer patients. J Clin Oncol. 12:1994;2248-2253.
9. Port RE, Daniel B, Ding RW, Herrman R. Relative importance of dose, body surface area, sex, and age for 5-fluorouracil clearance. Oncology. 48:1991;277-281.
10. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
11. Tateishi T, Nakura H, Watanabe M, Tanaka M, Kumai T, Kobayashi S. Preliminary examination of the influence of incubation time or cytosolic protein concentration on dihydropyrimidine dehydrogenase activity. Clin Chim Acta. 252:1996;1-19.
12. Zaphiropoulos PG, Mode A, Norstedt G, Gustafsson J-. Regulation of sexual differentiation in drug and steroid metabolism. Trends Pharmacol Sci. 10:1989;149-153.